Fund shareholders of Cytokinetics Inc
ISIN US23282W6057 · United States · LEI 549300BE5DY1HW7IHA64
- Fund shareholders
- 463
- Of which ETFs
- 86 377 other funds
- Value held
- 4.6B $ 355.9M SEK
- Share of capital
- 50.8 % of 139M shares on Aug 4, 2026
463 funds hold this company: 461 declare it in a regulatory filing, and this table serves those page by page; 2 more are read from the reports their funds publish, and are not in it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 5,105,689 | 336.5M $ | 0.51 % | 3.67 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Mid-Cap ETF iShares Trust | 4,048,023 | 266.8M $ | 0.25 % | 2.91 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,902,739 | 257.2M $ | 0.01 % | 2.81 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 3,482,614 | 222.8M $ | 0.60 % | 2.51 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 2,923,781 | 192.7M $ | 0.27 % | 2.10 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,839,773 | 187.2M $ | 0.11 % | 2.04 % | as of Mar 31, 2026 ↗ |
| Fidelity OTC Portfolio Fidelity Securities Fund | 2,271,300 | 145.3M $ | 0.36 % | 1.63 % | as of Apr 30, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 2,114,898 | 139.4M $ | 0.17 % | 1.52 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 1,686,600 | 111.2M $ | 0.49 % | 1.21 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,590,770 | 104.8M $ | 0.27 % | 1.14 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,365,835 | 90M $ | 0.11 % | 0.98 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1,331,453 | 87.8M $ | 1.18 % | 0.96 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1,183,484 | 75.7M $ | 0.23 % | 0.85 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 1,178,125 | 77.7M $ | 0.84 % | 0.85 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 1,100,581 | 72.5M $ | 0.52 % | 0.79 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 1,072,574 | 70.7M $ | 0.88 % | 0.77 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1,045,102 | 68.9M $ | 1.11 % | 0.75 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 929,552 | 57.8M $ | 0.03 % | 0.67 % | as of Feb 28, 2026 ↗ |
| iShares Russell 2000 Value ETF iShares Trust | 912,972 | 60.2M $ | 0.48 % | 0.66 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 896,972 | 59.1M $ | 0.73 % | 0.65 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 684,813 | 43.8M $ | 0.20 % | 0.49 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 663,136 | 43.7M $ | 0.40 % | 0.48 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 645,140 | 40.1M $ | 0.10 % | 0.46 % | as of Feb 28, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 600,000 | 37.3M $ | 0.60 % | 0.43 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF SPDR SERIES TRUST | 597,189 | 39.4M $ | 0.25 % | 0.43 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 593,636 | 36.9M $ | 0.18 % | 0.43 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 586,266 | 38.6M $ | 0.89 % | 0.42 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 578,745 | 36M $ | 0.24 % | 0.42 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 561,677 | 35.9M $ | 0.43 % | 0.40 % | as of Apr 30, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 510,356 | 33.6M $ | 0.51 % | 0.37 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 503,175 | 31.3M $ | 0.59 % | 0.36 % | as of Feb 28, 2026 ↗ |
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 502,775 | 32.2M $ | 0.46 % | 0.36 % | as of Apr 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 479,028 | 31.6M $ | 1.99 % | 0.34 % | as of Mar 31, 2026 ↗ |
| iShares S&P Mid-Cap 400 Growth ETF iShares Trust | 400,888 | 26.4M $ | 0.27 % | 0.29 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 400,000 | 25.6M $ | 0.55 % | 0.29 % | as of Apr 30, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 382,314 | 25.2M $ | 0.54 % | 0.27 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Small Cap Opportunities Fund Fidelity Securities Fund | 353,776 | 22.6M $ | 0.45 % | 0.25 % | as of Apr 30, 2026 ↗ |
| SmallCap Fund Principal Funds, Inc | 349,900 | 22.4M $ | 1.06 % | 0.25 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 341,233 | 21.2M $ | 0.10 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Small Cap Growth Fund American Century Mutual Funds, Inc. | 334,272 | 21.4M $ | 0.42 % | 0.24 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 330,605 | 20.6M $ | 0.15 % | 0.24 % | as of Feb 28, 2026 ↗ |
| Fidelity Puritan Fund Fidelity Puritan Trust | 329,900 | 20.5M $ | 0.06 % | 0.24 % | as of Feb 28, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 319,300 | 21M $ | 0.52 % | 0.23 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 312,871 | 20M $ | 1.05 % | 0.23 % | as of Apr 30, 2026 ↗ |
| VIP Mid Cap Portfolio Variable Insurance Products Fund III | 307,200 | 20.2M $ | 0.25 % | 0.22 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Equity Growth Fund Fidelity Advisor Series I | 291,801 | 18.2M $ | 0.15 % | 0.21 % | as of Feb 28, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 290,400 | 18.1M $ | 0.02 % | 0.21 % | as of Feb 28, 2026 ↗ |
| iShares S&P Mid-Cap 400 Value ETF iShares Trust | 285,745 | 18.8M $ | 0.24 % | 0.21 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 281,164 | 18M $ | 0.42 % | 0.20 % | as of Apr 30, 2026 ↗ |
| VIP Growth Portfolio Variable Insurance Products Fund | 269,100 | 17.7M $ | 0.17 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 267,000 | 17.1M $ | 0.59 % | 0.19 % | as of Apr 30, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 262,688 | 16.8M $ | 0.23 % | 0.19 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 249,600 | 16.5M $ | 0.13 % | 0.18 % | as of Mar 31, 2026 ↗ |
| Lannebo Global Lannebo Kapitalförvaltning AB | 228,000 | 143.2M SEK | 0.71 % | 0.16 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 227,934 | 14.2M $ | 0.01 % | 0.16 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 218,000 | 13.9M $ | 0.48 % | 0.16 % | as of Apr 30, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 214,074 | 13.7M $ | 0.56 % | 0.15 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 205,700 | 13.6M $ | 0.49 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Hälsovård Tema Handelsbanken Fonder AB | 205,000 | 128.7M SEK | 0.58 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Value Fund Fidelity Securities Fund | 203,453 | 13M $ | 0.26 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Fidelity OTC K6 Portfolio Fidelity Securities Fund | 203,400 | 13M $ | 0.39 % | 0.15 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 202,652 | 13.4M $ | 0.61 % | 0.15 % | as of Mar 31, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 202,120 | 12.6M $ | 0.60 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 194,679 | 12.8M $ | 0.27 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Small/Mid Cap Growth Alpha ETF Janus Detroit Street Trust | 189,801 | 12.1M $ | 1.24 % | 0.14 % | as of Apr 30, 2026 ↗ |
| VANGUARD S&P MID-CAP 400 INDEX FUND VANGUARD ADMIRAL FUNDS | 186,109 | 11.6M $ | 0.22 % | 0.13 % | as of Feb 28, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 184,777 | 11.5M $ | 0.18 % | 0.13 % | as of Feb 27, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 180,870 | 11.3M $ | 0.01 % | 0.13 % | as of Feb 28, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 172,745 | 10.7M $ | 0.23 % | 0.12 % | as of Feb 27, 2026 ↗ |
| American Funds Global Insight Fund American Funds Global Insight Fund | 161,996 | 10.4M $ | 0.05 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Small Cap Fund Fidelity Advisor Series I | 161,200 | 10M $ | 0.45 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 161,063 | 10.3M $ | 0.99 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 160,000 | 10.5M $ | 0.05 % | 0.12 % | as of Mar 31, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 158,500 | 10.4M $ | 0.38 % | 0.11 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 157,441 | 10.4M $ | 0.01 % | 0.11 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Equity Fund JNL Series Trust | 152,896 | 10.1M $ | 1.11 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Discovery Fund Fidelity Hastings Street Trust | 149,801 | 9.9M $ | 0.17 % | 0.11 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 148,708 | 9.8M $ | 0.12 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 146,000 | 9.6M $ | 0.51 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 143,425 | 9.2M $ | 0.23 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 138,684 | 9.1M $ | 0.04 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced Small Cap ETF Fidelity Covington Trust | 133,319 | 8.8M $ | 0.21 % | 0.10 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 131,757 | 8.4M $ | 0.36 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust | 131,696 | 8.7M $ | 0.48 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Columbia Small Cap Value and Inflection Fund COLUMBIA FUNDS SERIES TRUST | 128,610 | 8M $ | 0.97 % | 0.09 % | as of Feb 28, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 125,119 | 8.2M $ | 0.24 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Impax Small Cap Fund IMPAX FUNDS SERIES TRUST I | 125,000 | 8.2M $ | 1.11 % | 0.09 % | as of Mar 31, 2026 ↗ |
| JNL Mid Cap Index Fund JNL Series Trust | 123,477 | 8.1M $ | 0.25 % | 0.09 % | as of Mar 31, 2026 ↗ |
| William Blair Small Cap Growth Fund WILLIAM BLAIR FUNDS | 120,490 | 7.9M $ | 0.80 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Voya Small Cap Growth Fund Voya Equity Trust | 120,263 | 7.5M $ | 0.40 % | 0.09 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Small Cap Core Fund Fidelity Concord Street Trust | 115,651 | 7.4M $ | 0.46 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Small/Mid Cap Growth Fund Goldman Sachs Trust | 112,482 | 7M $ | 0.57 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 112,392 | 7.4M $ | 0.00 % | 0.08 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 108,545 | 7.2M $ | 0.06 % | 0.08 % | as of Mar 31, 2026 ↗ |
| William Blair Small-Mid Cap Growth Fund WILLIAM BLAIR FUNDS | 108,500 | 7.2M $ | 0.64 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Stock Selector Mid Cap Fund Fidelity Advisor Series I | 107,100 | 6.7M $ | 0.29 % | 0.08 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S & P 400(TM) Mid Cap Growth ETF SPDR SERIES TRUST | 100,517 | 6.6M $ | 0.27 % | 0.07 % | as of Mar 31, 2026 ↗ |
| EQ/Mid Cap Index Portfolio EQ Advisors Trust | 100,218 | 6.6M $ | 0.25 % | 0.07 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 100,000 | 6.6M $ | 0.66 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Value Fund Goldman Sachs Trust | 99,713 | 6.2M $ | 0.66 % | 0.07 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Thornburg Focus Growth Fund THORNBURG INVESTMENT TRUST | 2.78 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 2.06 % | as of Sep 30, 2025 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.99 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1.54 % | as of Mar 31, 2026 ↗ |
| Tema Heart & Health ETF Tema ETF Trust | 1.47 % | as of Feb 28, 2026 ↗ |
| Brown Advisory Sustainable Small-Cap Core Fund Brown Advisory Funds | 1.44 % | as of Mar 31, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 1.38 % | as of Feb 28, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.35 % | as of Feb 28, 2026 ↗ |
| AMG GW&K Small Cap Value Fund AMG Funds | 1.28 % | as of Mar 31, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 1.26 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 454 | +19 | 70,064,407 | -2.3 % |
| 2026Q1 | 435 | +36 | 71,728,244 | +5.3 % |
| 2025Q4 | 399 | +13 | 68,118,302 | +1.9 % |
| 2025Q3 | 386 | -18 | 66,855,548 | +8.4 % |
| 2025Q2 | 404 | -4 | 61,652,413 | -1.6 % |
| 2025Q1 | 408 | 0 | 62,648,882 | +0.2 % |
| 2024Q4 | 408 | +3 | 62,522,434 | +5.5 % |
| 2024Q3 | 405 | -12 | 59,278,765 | +17.2 % |
| 2024Q2 | 417 | +46 | 50,562,274 | -7.4 % |
| 2024Q1 | 371 | +30 | 54,588,837 | -5.1 % |
| 2023Q4 | 341 | 57,517,240 |
Institutional managers
429 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 17,523,840 | 1.2M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 16,548,011 | 1.1B $ | as of Mar 31, 2026 |
| FMR LLC | 10,723,140 | 706.8M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 8,009,489 | 527.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 5,745,193 | 378.7M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 3,333,333 | 219.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,215,415 | 212M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 3,125,436 | 206M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 2,721,158 | 179.4M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,205,758 | 145.4M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,077,277 | 136.9M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 1,661,248 | 109.5M $ | as of Mar 31, 2026 |
| Integral Health Asset Management, LLC | 1,600,000 | 105.5M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,584,321 | 104.4K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,505,075 | 99.2M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 1,480,857 | 97.6M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,441,634 | 95M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,397,045 | 92.1M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 1,374,320 | 90.6M $ | as of Mar 31, 2026 |
| Capital International Investors | 1,338,803 | 88.2M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 1,159,879 | 76.4M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,099,858 | 72.5M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 1,093,485 | 72.1M $ | as of Mar 31, 2026 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1,087,591 | 71.7M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 1,006,185 | 66.3M $ | as of Mar 31, 2026 |
Declared shareholders of Cytokinetics Inc
2 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 9.00 % | 11,135,192 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.21 % | 6,422,042 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Cytokinetics Inc
32 funds declare 37 bond lines of this company; the 25 largest holdings follow. The amount is the one filed, never a share of the debt: no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Cytokinetics Inc". https://titelia.com/en/stocks/cytokinetics-inc-US23282W6057